Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status and phase

Withdrawn
Phase 2

Conditions

Heroin Dependence
Opioid-Related Disorders

Treatments

Drug: Opioid-Related Disorders

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000328
R01-11160-3
NIDA-11160-3
1R01DA011160 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to compare the clinical efficacy of the buprenorphine/naloxone combination tablet to methadone for opioid maintenance treatment.

Full description

S/A brief "Summary for the Public"

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Individuals must be at least 18 years of age, currently opioid dependent and meet FDA criteria for narcotic maintenance treatment. Co-morbid substance abuse or dependence disorders may also be present. Individuals must be healthy despite drug dependency.

Exclusion criteria

Individuals with evidence of an active Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical illness (e.g. liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems